NUTX
Nutex Health Inc.
Company overview
- Market capitalization
- $1.51B
- Employees
- 1,005
- Latest publication
- 2026-09-29
About Nutex Health Inc.
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20242024-03-31 · USD | Q2 20232023-06-30 · USD | Q4 20212021-12-31 · USD | Q4 20202020-12-31 · USD | Q3 20202020-09-30 · USD | Q2 20202020-06-30 · USD | Q3 20192019-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 210,752,000USD | 67,453,787USD | 58,924,454USD | 63,401,665USD | 106,133,487USD | 350,032USD | 378,588USD | 17,592USD |
| Cost Of Revenue | 49,912,000USD | 57,296,609USD | 49,277,531USD | 41,157,084USD | — | 210,894USD | 352,585USD | — |
| Gross Profit | 141,279,000USD | 10,157,178USD | 9,646,923USD | 22,244,581USD | — | 139,138USD | 26,003USD | 17,592USD |
| General And Administrative Expenses | 16,677,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 19,561,000USD | 8,707,577USD | 10,009,461USD | 6,707,601USD | 42,801,648USD | 767,177USD | 1,708,625USD | 361,262USD |
| Operating Income | 121,718,000USD | 1,449,601USD | -362,540USD | 15,536,980USD | 63,331,839USD | -628,039USD | -1,682,622USD | -363,754USD |
| Total Other Income Expense Net | -4,633,000USD | -1,602,423USD | -4,719,520USD | -2,189,238USD | -2,755,430USD | 2,384,193USD | 1,909,928USD | -9,995USD |
| Interest Expense | 4,671,000USD | 4,444,362USD | 4,843,048USD | 1,944,749USD | 1,742,357USD | 18,252USD | 249,283USD | 9,995USD |
| Labor And Related Expense | 42,751,000USD | — | — | — | — | — | — | — |
| Professional Fees | 1,082,000USD | — | — | — | — | — | — | — |
| Depreciation And Amortization | 5,317,000USD | 4,186,202USD | 4,176,768USD | 1,317,980USD | 712,360USD | 4,295USD | 91,706USD | 44,646USD |
| Income Before Tax | 117,085,000USD | -152,822USD | -5,082,058USD | 13,347,742USD | 60,576,409USD | 1,756,154USD | 227,306USD | -373,749USD |
| Income Tax Expense | 20,768,000USD | 389,665USD | -815,612USD | -126,244USD | — | -52,750USD | -51,116USD | -44,646USD |
| Net Income | 96,317,000USD | -364,075USD | -3,479,047USD | 13,978,514USD | 40,253,571USD | 1,756,154USD | 227,306USD | -373,749USD |
| Minority Interest | 30,475,000USD | 178,412USD | -787,399USD | 1,405,911USD | — | — | — | — |
| Selling General Administrative | — | 8,707,577USD | 10,009,461USD | 394,619USD | 41,089,288USD | 698,598USD | 1,341,701USD | 187,295USD |
| Selling And Marketing Expenses | — | 637,159USD | — | 970,241USD | — | 5,248USD | 52,669USD | — |
| Net Interest Income | — | -4,444,362USD | -4,843,048USD | -1,944,749USD | — | — | — | — |
| Tax Provision | — | 389,665USD | -815,612USD | — | — | — | — | — |
| Net Income From Continuing Ops | — | -542,487USD | -4,266,446USD | 13,649,798USD | — | — | — | — |
| Ebit | — | 4,291,540USD | -239,010USD | 19,090,696USD | 41,995,928USD | 1,774,411USD | 476,591USD | -408,400USD |
| Ebitda | — | 8,477,742USD | 3,937,758USD | 20,408,676USD | 42,708,288USD | 1,778,706USD | 568,297USD | -363,754USD |
| Reconciled Depreciation | — | 4,186,202USD | 4,169,160USD | 1,789,025USD | 712,360USD | — | — | — |
| Non Operating Income Net Other | — | — | 123,528USD | — | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | -3,479,047USD | — | 40,253,571USD | — | — | — |
| Research Development | — | — | — | 209,160USD | — | 73,827USD | 314,255USD | — |
| Unclassified Operating Expenses | — | — | — | 5,133,581USD | 1,712,360USD | — | — | — |
| Other Operating Expenses | — | — | — | — | — | — | — | 361,262USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20112011-12-31 · USD | FY 20102010-12-31 · USD | FY 20092009-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 91,373USD | 53,647USD | — | — | 2,548,653USD | 1,266,360USD | 220,469USD |
| Cost Of Revenue | 62,298USD | 564,367USD | 473USD | 662USD | 1,529,498USD | 783,172USD | 94,916USD |
| Gross Profit | 29,075USD | 53,647USD | -473USD | -662USD | 1,019,155USD | 483,188USD | 125,553USD |
| Research Development | 545,223USD | 25,645USD | — | — | — | — | — |
| Selling General Administrative | 1,163,766USD | 1,813,624USD | — | — | 1,863,732USD | 1,829,401USD | 809,542USD |
| Total Operating Expenses | 1,797,338USD | 5,685,605USD | 448,122USD | 532,326USD | 1,863,732USD | 1,829,401USD | 809,542USD |
| Operating Income | -1,830,561USD | -5,692,920USD | -448,600USD | -532,990USD | -844,577USD | -1,346,213USD | -683,989USD |
| Interest Expense | 642,070USD | 367,352USD | 2,579USD | 3,146USD | — | — | — |
| Income Before Tax | -2,814,245USD | 582,062USD | -451,060USD | -536,130USD | -815,438USD | -1,337,941USD | -680,081USD |
| Income Tax Expense | -161,141USD | -535,024USD | 6,981,178USD | -619,941USD | -432,045USD | -1,496,078USD | -1,285,369USD |
| Net Income | -2,814,245USD | 582,062USD | -7,432,241USD | 83,809USD | -383,393USD | 158,137USD | 605,288USD |
| Ebit | -1,830,561USD | -5,692,920USD | -448,481USD | -532,984USD | -844,577USD | -1,346,213USD | -683,989USD |
| Ebitda | -1,830,561USD | -5,692,920USD | -448,008USD | -532,322USD | -844,577USD | -1,346,213USD | -683,989USD |
| Depreciation And Amortization | 522USD | 535,024USD | 473USD | 662USD | 5,915USD | 1,496USD | — |
| Total Other Income Expense Net | -983,684USD | 6,274,982USD | -2,460USD | -3,142USD | 29,139USD | 8,272USD | 3,908USD |
| Unclassified Operating Expenses | — | 3,846,336USD | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 964,629,000USD | 957,318,000USD | 918,525,000USD | 964,518,000USD | 841,028,000USD | 761,916,000USD | 655,320,393USD | 438,488,604USD |
| Cash And Equivalents | 205,208,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 585,650,000USD | 579,649,000USD | 538,811,000USD | 592,651,000USD | 473,025,000USD | 401,517,000USD | 292,478,885USD | 119,795,334USD |
| Other Current Assets | 17,635,000USD | 28,063,000USD | 24,953,000USD | 36,036,000USD | 19,060,000USD | 14,330,000USD | 9,996,244USD | 7,881,549USD |
| Other Non Current Assets | 3,561,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 457,317,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 117,220,000USD | 184,436,000USD | 157,911,000USD | 185,456,000USD | 194,874,000USD | 176,566,000USD | 140,866,125USD | 67,558,746USD |
| Total Stockholder Equity | 394,316,000USD | 346,293,000USD | 329,447,000USD | 317,166,000USD | 235,250,000USD | 197,108,000USD | 146,344,749USD | 79,778,425USD |
| Total Equity Including Noncontrolling Interest | 507,312,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 8,496,000USD | 16,874,000USD | 14,076,000USD | 23,308,000USD | 26,810,000USD | 20,761,000USD | 17,949,486USD | 13,884,049USD |
| Long Term Debt | 31,105,000USD | 24,261,000USD | 29,174,000USD | 25,574,000USD | 20,463,000USD | 21,733,000USD | 22,465,896USD | 26,801,811USD |
| Inventory | 4,207,000USD | 4,679,000USD | 2,866,000USD | 3,158,000USD | 2,275,000USD | 3,118,000USD | 2,849,814USD | 2,259,168USD |
| Property Plant Equipment Net | 121,852,000USD | 342,177,000USD | 343,903,000USD | 335,894,000USD | 326,064,000USD | 320,090,000USD | 324,693,925USD | 288,151,217USD |
| Goodwill | 13,919,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 20,580,000USD | 20,905,000USD | 21,230,000USD | 21,555,000USD | 14,880,000USD | 15,205,000USD | 15,530,281USD | 15,855,392USD |
| Short Term Debt | 2,238,000USD | 26,414,000USD | 23,305,000USD | 32,527,000USD | — | 30,891,000USD | 27,734,299USD | 17,821,748,000USD |
| Common Stock | 7,000USD | 7,000USD | 7,000USD | 7,000USD | — | 6,000USD | 5,511USD | 5,216USD |
| Retained Earnings | -173,538,000USD | -239,380,000USD | -286,187,000USD | -298,021,000USD | -353,456,000USD | -342,259,000USD | -356,893,371USD | -418,588,975USD |
| Total Liab | — | 515,265,000USD | 495,088,000USD | 526,485,000USD | 504,151,000USD | 487,036,000USD | 453,428,516USD | 358,710,179USD |
| Other Current Liab | — | 92,056,000USD | 84,772,000USD | 103,372,000USD | — | 74,853,000USD | 72,053,479USD | 39,416,065USD |
| Capital Stock | — | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 6,000USD | 5,511USD | 5,216USD |
| Good Will | — | 13,919,000USD | 13,919,000USD | 13,919,000USD | 13,919,000USD | 13,919,000USD | 13,918,719USD | 13,918,719,000USD |
| Cash | — | 207,347,000USD | 185,574,000USD | 166,048,000USD | 96,733,000USD | 84,729,000USD | 43,581,412USD | 46,909,281USD |
| Cash And Short Term Investments | — | 207,347,000USD | 185,574,000USD | 166,048,000USD | — | 84,729,000USD | 43,581,412USD | 46,909,281USD |
| Net Debt | — | 141,739,000USD | 165,819,000USD | 222,976,000USD | — | 256,632,000USD | 296,715,278USD | 252,945,792USD |
| Short Long Term Debt Total | — | 349,086,000USD | 351,393,000USD | 389,024,000USD | — | 341,361,000USD | 340,296,690USD | 299,855,073USD |
| Net Receivables | — | 339,560,000USD | 325,418,000USD | 387,409,000USD | 354,957,000USD | 299,340,000USD | 236,051,415USD | 62,745,336,000USD |
| Accounts Payable | — | 50,372,000USD | 48,967,000USD | 49,557,000USD | 30,051,000USD | 25,515,000USD | 13,958,959USD | 10,320,933USD |
| Property Plant Equipment Gross | — | 375,775,000USD | 375,599,000USD | 365,924,000USD | 354,626,000USD | 347,012,000USD | 349,965,209USD | 311,756,157USD |
| Common Stock Shares Outstanding | — | 7,177,528shares | 7,177,528shares | 7,177,528shares | 6,595,109shares | 5,853,000shares | 5,100,030shares | 7,454,551shares |
| Non Current Assets Total | — | 377,669,000USD | 379,714,000USD | 371,867,000USD | 368,003,000USD | 360,399,000USD | 362,841,508USD | 318,693,270USD |
| Non Current Liabilities Total | — | 330,829,000USD | 337,177,000USD | 341,029,000USD | 309,277,000USD | 310,470,000USD | 312,562,391USD | 291,151,433USD |
| Non Currrent Assets Other | — | 668,000USD | 662,000USD | 499,000USD | 288,000USD | 698,000USD | 711,347USD | 767,942USD |
| Net Working Capital | — | 395,213,000USD | 380,900,000USD | 407,195,000USD | 278,151,000USD | 224,951,000USD | 151,612,760USD | 52,236,588USD |
| Unclassified Non Current Liabilities | — | 306,568,000USD | 308,003,000USD | 315,455,000USD | 288,814,000USD | 288,737,000USD | 290,096,495USD | 264,349,622USD |
| Unclassified Equity | — | 585,659,000USD | 615,620,000USD | 615,173,000USD | 588,699,000USD | 539,355,000USD | 503,227,098USD | 498,356,968USD |
| Unclassified Current Liabilities | — | — | -13,209,000USD | -23,308,000USD | 138,013,000USD | 24,546,000USD | 9,169,902USD | -17,817,810,301USD |
| Unclassified Non Current Assets | — | — | — | — | 12,852,000USD | 10,487,000USD | 7,987,236USD | -13,904,800,281USD |
| Short Term Investments | — | — | — | — | — | — | -710,635,653USD | 46,862,371,719USD |
| Unclassified Current Assets | — | — | — | — | — | — | 43,581,412USD | -109,544,962,383USD |
| Other Assets | — | — | — | — | — | — | — | -438,050,115,396USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -49,712,753,325USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 918,525,000USD | 655,320,393USD | 398,245,497USD | 431,751,985USD | 394,650,043USD | 308,554,805USD | 179,224,529USD | 449,428USD |
| Intangible Assets | 21,230,000USD | 15,530,281USD | 20,512,636USD | 21,191,390USD | 682,649USD | — | 1,535,974USD | 2,572,015USD |
| Other Current Assets | 24,953,000USD | 9,996,244USD | 2,679,394USD | 1,869,806USD | 323,283USD | 130,569USD | 700,074USD | -27,073USD |
| Total Liab | 495,088,000USD | 453,428,516USD | 319,139,391USD | 311,424,585USD | 203,069,033USD | 161,185,980USD | 128,388,954USD | 1,946,781USD |
| Total Stockholder Equity | 329,447,000USD | 146,344,749USD | 61,453,190USD | 95,862,701USD | 114,651,306USD | 85,806,895USD | 28,309,764USD | -1,497,353USD |
| Other Current Liab | 84,772,000USD | 72,053,479USD | 12,955,296USD | 8,811,023USD | 6,690,507USD | 2,396,634USD | 6,531,119USD | 332,194USD |
| Common Stock | 7,000USD | 5,511USD | 676,680USD | 650,224USD | 592,792USD | 5,282USD | 4,649USD | 1,775USD |
| Capital Stock | 7,000USD | 5,511USD | 676,680USD | 650,224USD | 592,792USD | — | — | — |
| Retained Earnings | -286,187,000USD | -356,893,371USD | -409,072,539USD | -363,285,925USD | 102,315,623USD | -18,218,962USD | -12,568,795USD | -5,452,275USD |
| Good Will | 13,919,000USD | 13,918,719USD | 17,066,263USD | 17,010,637USD | 1,139,297USD | 1,139,297USD | 3,471,508USD | — |
| Cash | 185,574,000USD | 43,581,412USD | 22,002,056USD | 34,255,264USD | 36,118,284USD | 25,514,275USD | 8,004,250USD | 119,267USD |
| Cash And Short Term Investments | 185,574,000USD | 43,581,412USD | 22,002,056USD | 34,255,264USD | 36,118,284USD | 25,514,275USD | 8,004,250USD | 119,267USD |
| Total Current Assets | 538,811,000USD | 292,478,885USD | 90,848,403USD | 97,973,924USD | 154,015,179USD | 135,507,414USD | 45,743,237USD | 305,417USD |
| Total Current Liabilities | 157,911,000USD | 140,866,125USD | 58,313,052USD | 54,862,969USD | 37,690,959USD | 31,451,016USD | 72,132,916USD | 1,044,060USD |
| Net Debt | 165,819,000USD | 296,715,278USD | 253,754,892USD | 232,946,249USD | 142,433,221USD | 124,605,759USD | 111,935,366USD | 1,260,508USD |
| Short Term Debt | 23,305,000USD | 27,734,299USD | 20,076,363USD | 21,092,108USD | 13,173,431USD | 20,385,070USD | 63,683,578USD | 477,055USD |
| Short Long Term Debt | 14,076,000USD | 17,949,486USD | 14,180,397USD | 15,169,576USD | 10,230,987USD | 18,645,091USD | 13,353,451USD | — |
| Short Long Term Debt Total | 351,393,000USD | 340,296,690USD | 275,756,948USD | 267,201,513USD | 178,551,505USD | 150,120,034USD | 119,939,616USD | 1,379,775USD |
| Long Term Debt | 29,174,000USD | 22,465,896USD | 26,314,733USD | 23,051,152USD | 78,821,985USD | 81,903,657USD | 40,877,963USD | — |
| Net Receivables | 325,418,000USD | 236,051,415USD | 62,776,369USD | 58,315,569USD | 114,759,434USD | 108,136,880USD | 36,138,998USD | 186,150USD |
| Inventory | 2,866,000USD | 2,849,814USD | 3,390,584USD | 3,533,285USD | 2,814,178USD | 1,725,689USD | 899,915USD | 27,073USD |
| Accounts Payable | 48,967,000USD | 13,958,959USD | 25,281,393USD | 23,930,048USD | 17,653,102USD | 8,630,661USD | 1,752,659USD | 567,006USD |
| Property Plant Equipment Net | 343,903,000USD | 324,693,925USD | 269,387,060USD | 295,152,608USD | 238,356,833USD | 170,809,411USD | 131,279,524USD | 7,612USD |
| Property Plant Equipment Gross | 375,599,000USD | 349,965,209USD | 287,728,123USD | 295,152,608USD | 249,945,424USD | 177,373,332USD | 134,418,526USD | — |
| Common Stock Shares Outstanding | 6,756,108shares | 5,100,030shares | 4,408,319shares | 4,232,520shares | 3,951,947shares | 4,291,578shares | 4,139,627shares | 7,184,203shares |
| Non Current Assets Total | 379,714,000USD | 362,841,508USD | 307,397,094USD | 333,778,061USD | 240,634,864USD | 173,047,391USD | 133,481,293USD | 144,011USD |
| Non Current Liabilities Total | 337,177,000USD | 312,562,391USD | 260,826,339USD | 256,561,616USD | 165,378,074USD | 129,734,964USD | 56,256,038USD | 902,720USD |
| Non Currrent Assets Other | 662,000USD | 711,347USD | 431,135USD | 423,426USD | 456,085USD | 1,098,683USD | -2,805,713USD | 19,435USD |
| Net Working Capital | 380,900,000USD | 151,612,760USD | 32,535,351USD | 43,110,955USD | 116,324,220USD | 104,056,398USD | -26,389,679USD | — |
| Unclassified Current Liabilities | -13,209,000USD | 9,169,902USD | -14,180,397USD | -14,139,786USD | -10,230,987USD | -18,645,091USD | -13,353,451USD | — |
| Unclassified Non Current Liabilities | 308,003,000USD | 290,096,495USD | 234,511,606USD | 223,058,253USD | 86,556,089USD | 47,831,307USD | 15,378,075USD | — |
| Unclassified Equity | 615,620,000USD | 503,227,098USD | 469,172,369USD | 457,848,178USD | 11,150,099USD | 104,020,575USD | 40,873,910USD | 3,953,147USD |
| Short Term Investments | — | -710,635,653USD | — | — | — | — | — | — |
| Unclassified Current Assets | — | 43,581,412USD | — | — | — | — | — | — |
| Unclassified Non Current Assets | — | 7,987,236USD | — | — | — | — | -2,805,713USD | -2,455,051USD |
| Other Liab | — | — | — | 10,452,211USD | — | — | — | — |
| Other Assets | — | — | — | 423,426USD | 456,085USD | 1,098,683USD | -1USD | — |
| Net Tangible Assets | — | — | — | 57,660,674USD | 112,829,360USD | 84,667,598USD | 27,170,467USD | — |
| Current Deferred Revenue | — | — | — | — | 173,919USD | 38,651USD | 165,560USD | 9,192USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 62,763,000USD | 11,834,000USD | 96,799,000USD | -17,697,000USD | 44,223,000USD | 99,969,188USD | -7,165,010USD | 3,009,743USD |
| Depreciation | 5,492,000USD | 5,187,000USD | 5,003,000USD | 5,248,000USD | 5,092,000USD | 5,280,488USD | 4,972,478USD | 4,533,006USD |
| Stock Based Compensation | -3,915,000USD | -2,603,000USD | 13,217,000USD | 78,747,000USD | 36,094,000USD | 14,680,454USD | 1,963,518USD | -61,074USD |
| Other Non Cash Items | 33,000USD | 2,317,000USD | 252,000USD | 251,000USD | 253,000USD | 662,327USD | 7,312,000USD | 4,176,187USD |
| Change To Account Receivables | -20,481,000USD | 81,489,000USD | -51,905,000USD | -55,614,000USD | -63,289,000USD | -169,703,890USD | -1,129,526USD | 397,371USD |
| Change To Inventory | -1,813,000USD | 292,000USD | -883,000USD | 843,000USD | -268,000USD | -590,646USD | 500,280USD | 216,136USD |
| Change In Working Capital | 12,077,000USD | 56,917,000USD | -43,564,000USD | -70,768,000USD | -32,197,000USD | -109,148,794USD | -891,983USD | 3,848,269USD |
| Total Cash From Operating Activities | 75,518,000USD | 70,389,000USD | 99,514,000USD | 27,257,000USD | 50,965,000USD | 53,462USD | 6,789,476USD | 13,259,869USD |
| Capital Expenditures | -1,201,000USD | -1,409,000USD | -302,000USD | -751,000USD | -64,000USD | -395,246USD | -617,159USD | -558,492USD |
| Free Cash Flow | 74,317,000USD | 68,980,000USD | 99,212,000USD | 26,506,000USD | 50,901,000USD | -341,784USD | 6,172,317USD | 12,701,377USD |
| Total Cashflows From Investing Activities | -1,201,000USD | -5,072,000USD | -302,000USD | — | -64,000USD | -395,246USD | -267,178USD | -1,269,798USD |
| Net Borrowings | -3,701,000USD | -9,140,000USD | -6,573,000USD | -4,279,000USD | 552,000USD | -4,171,793USD | -84,000USD | — |
| Total Cash From Financing Activities | -49,549,000USD | -45,791,000USD | -29,897,000USD | -15,449,000USD | -6,812,000USD | -2,986,085USD | -420,992USD | -1,188,152USD |
| Dividends Paid | -15,357,000USD | -32,102,000USD | -23,398,000USD | -11,412,000USD | -7,364,000USD | -2,778,738USD | -1,797,665USD | -1,380,563USD |
| Sale Purchase Of Stock | -31,730,000USD | -5,000,000USD | — | — | 0USD | — | — | — |
| Change In Cash | 24,768,000USD | 19,823,000USD | 69,315,000USD | 12,004,000USD | 44,089,000USD | -3,327,869USD | 6,101,306USD | 10,801,975USD |
| Begin Period Cash Flow | 185,871,000USD | 166,048,000USD | 96,733,000USD | 84,729,000USD | 43,581,000USD | 46,909,281USD | 40,807,975USD | 30,006,000USD |
| End Period Cash Flow | 210,639,000USD | 185,871,000USD | 166,048,000USD | 96,733,000USD | 87,670,000USD | 43,581,412USD | 46,909,281USD | 40,807,975USD |
| Other Cashflows From Investing Activities | -1,201,000USD | -4,312,000USD | -1,994,000USD | — | -3,015,203USD | -2,665,571,981USD | 349,981USD | -711,306USD |
| Other Cashflows From Financing Activities | 1,239,000USD | -31,651,000USD | 74,000USD | — | -7,364,000USD | 13,166,946USD | 660,063USD | 300,850USD |
| Unclassified Investing Cash Flow | 1,201,000USD | — | 2,296,000USD | — | 3,079,203USD | 2,665,967,227USD | — | 1,269,475USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | -500USD | -500USD |
| Unclassified Operating Cash Flow | — | -3,263,000USD | 27,807,000USD | 31,476,000USD | -2,500,000USD | -11,390,201USD | — | -2,246,262USD |
| Unclassified Financing Cash Flow | — | 32,102,000USD | — | — | 7,364,000USD | -9,202,500USD | — | — |
| Investments | — | — | -302,000USD | 196,000USD | -64,000USD | -395,246USD | -267,178USD | -1,269,475USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20152015-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 180,357,000USD | 95,271,921USD | -43,423,715USD | -432,739,618USD | 168,525,285USD | 145,557,894USD | 32,089,376USD | -536,130USD |
| Depreciation | 20,530,000USD | 18,971,972USD | 17,591,572USD | 13,131,374USD | 7,662,464USD | 5,960,766USD | 2,477,576USD | 662USD |
| Stock Based Compensation | 117,003,000USD | 16,631,898USD | 2,835,971USD | 189,581USD | 10,344,239USD | 2,571,689USD | 450,054USD | — |
| Other Non Cash Items | 902,000USD | 9,808,225USD | 31,621,273USD | 400,713,661USD | -5,508,240USD | -580,636USD | -596,941USD | 563,788USD |
| Change To Account Receivables | -89,319,000USD | -173,407,045USD | -4,583,646USD | 58,077,067USD | -6,622,554USD | -71,234,706USD | -24,742,577USD | 56,697USD |
| Change To Inventory | -16,000USD | 540,770USD | 142,701USD | -719,107USD | -1,088,489USD | -825,773USD | -486,271USD | — |
| Change In Working Capital | -87,743,000USD | -104,397,219USD | -1,661,326USD | 64,315,901USD | 2,752,977USD | -69,673,754USD | -21,845,347USD | -116,580USD |
| Total Cash From Operating Activities | 248,125,000USD | 23,153,807USD | 1,256,452USD | 50,607,108USD | 173,432,486USD | 81,264,270USD | 12,124,664USD | 44,907USD |
| Capital Expenditures | -2,526,000USD | -2,303,897USD | -9,496,832USD | -14,632,414USD | -36,926,591USD | -61,191,925USD | -32,275,356USD | 0USD |
| Free Cash Flow | 245,599,000USD | 20,849,910USD | -8,240,380USD | 35,974,694USD | 136,505,895USD | 20,072,345USD | -20,150,692USD | 44,907USD |
| Investments | 1,596,000USD | -2,665,222USD | -4,225,431USD | -4,337,398USD | -36,975,444USD | -61,191,925USD | -31,234,106USD | — |
| Total Cashflows From Investing Activities | -5,242,000USD | -2,665,222USD | -11,239,882USD | -4,337,398USD | -36,975,444USD | -61,191,925USD | -31,234,106USD | 1,828USD |
| Net Borrowings | -19,440,000USD | -7,400,122USD | 2,646,771USD | -5,591,013USD | -3,221,008USD | 46,462,323USD | 35,569,025USD | — |
| Total Cash From Financing Activities | -97,949,000USD | 1,090,771USD | -2,269,778USD | -48,132,730USD | -125,853,033USD | -2,562,320USD | 21,713,333USD | -51,277USD |
| Dividends Paid | -74,276,000USD | -6,437,966USD | -5,214,581USD | -51,231,657USD | -144,337,923USD | -59,051,265USD | -18,903,003USD | — |
| Sale Purchase Of Stock | -5,000,000USD | 0USD | 0USD | 4,764,115USD | — | -120,000USD | -4,112,500USD | — |
| Issuance Of Capital Stock | 0USD | 9,202,500USD | 0USD | 0USD | — | — | — | — |
| Change In Cash | 145,231,000USD | 21,579,356USD | -12,253,208USD | -1,863,020USD | 10,604,009USD | 17,510,025USD | 2,603,892USD | -4,542USD |
| Begin Period Cash Flow | 40,640,000USD | 22,002,056USD | 34,255,264USD | 36,118,284USD | 25,514,275USD | 8,004,250USD | 5,400,358USD | 126,833USD |
| End Period Cash Flow | 185,871,000USD | 43,581,412USD | 22,002,056USD | 34,255,264USD | 36,118,284USD | 25,514,275USD | 8,004,250USD | 122,291USD |
| Other Cashflows From Investing Activities | -4,312,000USD | -2,665,222USD | — | 12,716,228USD | -48,853USD | -161,400USD | 12,852USD | 1,828USD |
| Other Cashflows From Financing Activities | 767,000USD | 5,726,359USD | 298,032USD | 8,010,159USD | 41,320,270USD | 71,849,698USD | 46,543,089USD | -51,277USD |
| Unclassified Operating Cash Flow | 17,076,000USD | -13,132,990USD | -5,707,323USD | 4,996,209USD | -10,344,239USD | -2,571,689USD | — | — |
| Unclassified Investing Cash Flow | — | 4,969,119USD | 2,482,381USD | 1,916,186USD | 36,975,444USD | 61,353,325USD | 32,262,504USD | — |
| Unclassified Financing Cash Flow | — | 9,202,500USD | — | -4,084,334USD | -19,614,372USD | -61,703,076USD | -37,383,278USD | — |
| Change To Liabilities | — | — | — | 8,377,080USD | 6,267,993USD | 2,580,271USD | 1,633,002USD | — |
| Cash And Cash Equivalents Changes | — | — | — | -1,863,020USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Hospital Division | 201,852,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Population Health Management Division | 8,900,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Hospital Division | 201,852,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Population Health Management Division | 8,900,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Real Estate Division | 1,177,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Hospital Division | 207,570,000 | USD | 0001628280-26-028849 |
| Q1 2026Quarterly · 2026-03-31 | Product | Population Health Management Division | 8,915,000 | USD | 0001628280-26-028849 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Hospital Division | 207,570,000 | USD | 0001628280-26-028849 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Population Health Management Division | 8,915,000 | USD | 0001628280-26-028849 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Real Estate Division | 1,177,000 | USD | 0001628280-26-028849 |
| Q4 2025Quarterly · 2025-12-31 | Product | Hospital Division | 143,674,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Population Health Management Division | 8,005,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Hospital Division | 143,674,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Population Health Management Division | 8,005,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Hospital Division | 844,162,000 | USD | 0001628280-26-015168 |
| FY 2025Yearly · 2025-12-31 | Product | Population Health Management Division | 31,095,000 | USD | 0001628280-26-015168 |
| FY 2025Yearly · 2025-12-31 | Segment | Hospital Division | 844,162,000 | USD | 0001628280-26-015168 |
| FY 2025Yearly · 2025-12-31 | Segment | Population Health Management Division | 31,095,000 | USD | 0001628280-26-015168 |
| FY 2025Yearly · 2025-12-31 | Segment | Real Estate Division | 2,490,000 | USD | 0001628280-26-015168 |
| Q3 2025Quarterly · 2025-09-30 | Product | Hospital Division | 260,239,000 | USD | 0001628280-25-053166 |
| Q3 2025Quarterly · 2025-09-30 | Product | Population Health Management Division | 7,565,000 | USD | 0001628280-25-053166 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Hospital Division | 260,239,000 | USD | 0001628280-25-053166 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Population Health Management Division | 7,565,000 | USD | 0001628280-25-053166 |
| Q2 2025Quarterly · 2025-06-30 | Product | Hospital Division | 236,302,000 | USD | 0001628280-25-052957 |
| Q2 2025Quarterly · 2025-06-30 | Product | Population Health Management Division | 7,683,000 | USD | 0001628280-25-052957 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Hospital Division | 236,302,000 | USD | 0001628280-25-052957 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Population Health Management Division | 7,683,000 | USD | 0001628280-25-052957 |
| Q1 2025Quarterly · 2025-03-31 | Product | Hospital Division | 203,947,000 | USD | 0001628280-26-028849 |
| Q1 2025Quarterly · 2025-03-31 | Product | Population Health Management Division | 7,842,000 | USD | 0001628280-26-028849 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Hospital Division | 203,947,000 | USD | 0001628280-26-028849 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Population Health Management Division | 7,842,000 | USD | 0001628280-26-028849 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Real Estate Division | 619,000 | USD | 0001628280-26-028849 |
| Q4 2024Quarterly · 2024-12-31 | Product | Hospital Division | 249,697,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Population Health Management Division | 7,922,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Hospital Division | 249,697,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Population Health Management Division | 7,922,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Hospital Division | 449,064,000 | USD | 0001628280-26-015168 |
| FY 2024Yearly · 2024-12-31 | Product | Population Health Management Division | 30,885,000 | USD | 0001628280-26-015168 |
| FY 2024Yearly · 2024-12-31 | Segment | Hospital Division | 449,064,000 | USD | 0001628280-26-015168 |
| FY 2024Yearly · 2024-12-31 | Segment | Population Health Management Division | 30,885,000 | USD | 0001628280-26-015168 |
| FY 2024Yearly · 2024-12-31 | Segment | Real Estate Division | 2,420,000 | USD | 0001628280-26-015168 |
| Q3 2024Quarterly · 2024-09-30 | Product | Hospital Division | 71,733,000 | USD | 0001628280-25-053166 |
| Q3 2024Quarterly · 2024-09-30 | Product | Population Health Management Division | 7,062,000 | USD | 0001628280-25-053166 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Hospital Division | 71,733,000 | USD | 0001628280-25-053166 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Population Health Management Division | 7,062,000 | USD | 0001628280-25-053166 |
| FY 2023Yearly · 2023-12-31 | Product | Hospital Division | 218,070,000 | USD | 0001628280-26-015168 |
| FY 2023Yearly · 2023-12-31 | Product | Population Health Management Division | 29,576,000 | USD | 0001628280-26-015168 |
| FY 2023Yearly · 2023-12-31 | Segment | Hospital Division | 218,070,000 | USD | 0001628280-26-015168 |
| FY 2023Yearly · 2023-12-31 | Segment | Other | 800,000 | USD | 0001628280-26-015168 |
| FY 2023Yearly · 2023-12-31 | Segment | Population Health Management Division | 29,576,000 | USD | 0001628280-26-015168 |
| FY 2023Yearly · 2023-12-31 | Segment | Real Estate Division | -800,000 | USD | 0001628280-26-015168 |
| FY 2022Yearly · 2022-12-31 | Product | Hospital Division | 198,508,245 | USD | 0001479681-25-000006 |
| FY 2022Yearly · 2022-12-31 | Product | Population Health Management Division | 20,786,061 | USD | 0001479681-25-000006 |
| FY 2022Yearly · 2022-12-31 | Segment | Hospital Division | 198,508,245 | USD | 0001479681-25-000006 |
| FY 2022Yearly · 2022-12-31 | Segment | Population Health Management Division | 20,786,061 | USD | 0001479681-25-000006 |
| FY 2022Yearly · 2022-12-31 | Segment | Real Estate Division | 269,699 | USD | 0001479681-25-000006 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.